Movianto supports Pinnacle Biologics' market entry into Europe
04 September 2008, Stuttgart/Germany
Pinnacle Biologics has appointed Movianto to provide exclusive logistics and distribution services to support the launch of the drug Ethyol in several European markets. As one of the leading European providers of distribution and logistics services for the pharmaceutical, biotechnology and healthcare industry, Movianto through its pan-European network of ten subsidiaries offers an ideal infrastructure and services portfolio along the whole supply chain.
Pinnacle Biologics, an US based company will benefit from Movianto’s expertise and solution competence in the European healthcare market. “This collaboration between Pinnacle and Movianto creates an alliance that we can jointly expand over time. I am very excited about the future possibilities of working with Movianto”, said James R. Miller, President and CEO of Pinnacle Biologics.
Movianto will distribute the product to hospitals and wholesalers in numerous European countries and will manage complete order-to-cash-collection.
Conor Roche, Managing Director of Movianto Group commented, “We fulfilled the significant requirements of Pinnacle’s novel business model, and implemented a distribution infrastructure that can expand as they grow. In addition, business models like the one developed with Pinnacle will provide ideal support for specialised pharmaceutical and biotechnology companies.”
| Download (44 KB) |
Press Contact
Movianto GmbH
Ottilie Krug
Neckartalstrasse 155
70376 Stuttgart
Germany
Tel +49 (0)711 900 597 912